Tags : University of Strathclyde

B2B

ClinSpec Diagnostics secures £1.1 million Seed Follow On investment led

Cancer diagnostics firm completes £3.5M funding round Thursday 4th March 2021 ClinSpec Diagnostics Limited (ClinSpec Dx), the Glasgow-based developer of liquid biopsies for early detection of cancer, has reached its round two funding target of £3.5M by securing an additional investment of £1.1M. The company, which is a spinout from the Department of Pure and Applied Chemistry […]Read More

HealthTech

ClinSpec Diagnostics secures £2.4 million Series A investment led by

Early cancer detection technology secures £2.4M funding boost Efforts to improve the early detection of cancer have received a significant boost with a £2.4 million funding deal to support the further development of innovative testing technology. Glasgow-based ClinSpec Diagnostics Limited (ClinSpec Dx), a spinout from the Department of Pure and Applied Chemistry at the University […]Read More

EnergyTech

Foresight invests £2.1 million into £2.9 million Series A investment

Synaptec’s innovative technology can reduce downtime and allow easier and cheaper monitoring of the increasingly complex electric power grid The Foresight Williams Technology EIS Fund invested £2 million alongside £100,000 from the newly created Foresight Scottish Growth Fund The funding will be used to scale-up production, grow international sales and exploit future data analytics opportunities […]Read More